Progress in the treatment of Neurofibromatosis type 2 / 中国医师杂志

ABSTRACT

Neurofibromatosis type 2 is an autosomal dominant inherited disease with a low incidence. It often involves the central and peripheral nervous systems, leading to bilateral hearing loss, balance difficulties, facial paralysis and other symptoms, which seriously affects the quality of life of patients. Therefore, in the treatment of neurofibromatosis type 2, preservation of facial nerve function is crucial. The diagnosis and treatment scheme should take into account the characteristics of the tumor and the patient′s wishes. Individualized programmes of multidisciplinary collaboration are needed.